TraceRx develops a blockchain-based supply chain platform that enhances transparency and traceability in pharmaceutical logistics. By utilizing distributed ledger technology, the platform addresses issues of counterfeit drugs and inefficient tracking, ensuring the integrity of the supply chain.
Funding
$300K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The pharmaceutical industry faces significant challenges in ensuring the integrity of its supply chain, leading to issues such as counterfeit drugs, theft, and inefficient tracking processes. These problems can result in financial losses, regulatory non-compliance, and, most importantly, risks to patient safety.
Solution
TraceRx offers a blockchain-based platform designed to enhance transparency and traceability throughout the pharmaceutical supply chain. By leveraging distributed ledger technology, the platform provides a secure and immutable record of each product's journey from manufacturer to patient. This enables real-time tracking, verification of authenticity, and improved collaboration among stakeholders, ultimately reducing the risk of counterfeit drugs and improving supply chain efficiency. The platform's features facilitate compliance with regulatory requirements and enhance trust among all parties involved in the distribution process.
Target Audience
The primary target audience includes pharmaceutical manufacturers, distributors, pharmacies, and healthcare providers seeking to improve supply chain transparency, reduce the risk of counterfeit drugs, and ensure patient safety.
Features
- Blockchain-based tracking and tracing of pharmaceutical products
- Secure and immutable record of product history
- Real-time visibility into product location and condition
- Verification of product authenticity to combat counterfeiting
- Improved collaboration and communication among supply chain stakeholders
- Compliance with regulatory requirements such as DSCSA